Hepatitis C virus infection (HCV) is the main cause for chronic hepatic disease around the world. Nowadays, there are highly sensitive and specialized tests such as third generation ELISA, used to detect anti-HCV antibodies and to prevent its transmission. Since 1998, this test has been applied to blood donors in our hospital. The objectives of this study were to determine the predominance and some epidemiological characteristics of the HCV infection in blood donors at the Cayetano Heredia National Hospital (C.H.N.H.). This is a descriptive and retrospective study; the epidemiological facts and general sieve results were obtained from the Blood Bank register from 1998 to June 2002. The third generation ELISA test was used. During the time period evaluated, 15,009 blood donors were examined and 122 positive cases were found (0.813% prevalence). The yearly prevalence in 1998 was 14 cases in 2960 donors (0,47%); in 1999, 25 cases in 3136 donors (0,79%); in 2000, 46 cases in 3311 donors (1,38%); in 2001, 21 cases in 3730 donors (0,56%); and in 2002, 16 cases in 1872 donors (0,85%). Likewise, 97 cases (79,5%) were males and 25 cases (20,5%) were females. Seroprevalence predominated in the age group from 21 to 30 (36,06%), followed by the age group from 31 to 40 (27,86%). 47 cases (38,5%) came from the Districts of Lima, Comas and San Martin de Porres. With respect to risky conducts, 79 cases (64,5%) reported having sexual relations without protection, 15 cases (12,29%) reported sexual relations with prostitutes, and only 4 cases (3,27%) reported having received blood transfusions before. In conclusion, the prevalence of the HCV infection in blood donors at the C.H.N.H. is 0,813% from 1998 to June 2002, and sexual relations without protection is the most frequent characteristic.

Download full-text PDF

Source

Publication Analysis

Top Keywords

blood donors
16
infection blood
12
cases
12
sexual relations
12
donors
10
virus infection
8
blood bank
8
donors hospital
8
cayetano heredia
8
third generation
8

Similar Publications

Syphilis-positive and false-positive trends among US blood donors, 2013-2023.

Transfusion

January 2025

Infectious Disease Consultant, North Potomac, Maryland, USA.

Background: US blood donors are tested for syphilis because the bacterial agent is transfusion transmissible. Here we describe trends over an 11-year period of donations positive for recent and past syphilis infections, and donations classified as syphilis false positive (FP).

Methods: Data from January 1, 2013, to December 31, 2023 (11 years) were compiled for all American Red Cross blood donations to evaluate demographics/characteristics and longitudinal trends in donors testing syphilis reactive/positive.

View Article and Find Full Text PDF

Despite progress in healthcare services for individuals living with sickle cell disease (SCD) in Africa, substantial gaps remain in advanced treatments for SCD. To help address this burden, Tanzania has established one of the largest single-centre SCD programmes in the world and developed an advanced therapy programme for SCD focused on patient engagement and advocacy, clinical activities involving exchange blood transfusion (ExBT) and haematopoietic stem cell transplant (HSCT), gene therapy (GT) preparedness, and enabling partnerships. This report describes the programme's genesis, structure and progress achieved.

View Article and Find Full Text PDF

Optimizing the long-term care and follow-up of living kidney donors (LKDs) has been challenging, and prior LKDs have reported suboptimal healthcare experiences. Long-term care of LKDs is largely undertaken by primary care practitioners such as family physicians (FPs). We conducted a cross-sectional survey of Canadian FPs (n = 151).

View Article and Find Full Text PDF

Low Neutralization of SARS-CoV-2 Omicron BA5248, XBB15 and JN1 by Homologous Booster and Breakthrough Infection.

J Med Virol

February 2025

Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, Zhejiang, P. R. China.

Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can be induced through either infection with the virus or vaccination, providing protection against reinfection or reducing the risk of severe clinical outcomes. In this study, we recruited 172 volunteers who received different vaccination regimens, including 124 individuals who had recovered from breakthrough infections caused by the Omicron variant (27 with 2 doses, 49 with 3 doses, and 48 with 4 doses) and 48 healthy donors who did not experience breakthrough infections (all of whom received a fourth dose during the infection wave). We measured neutralizing antibody levels against Omicron BA.

View Article and Find Full Text PDF

Among the various types of pancreatic cancers, pancreatic ductal adenocarcinoma (PDAC) is the most lethal and aggressive, due to its tendency to metastasize quickly and has a particularly low five-year survival rate. Carbohydrate antigen 19-9 (CA 19-9) is the only biomarker approved by the Food and Drug Administration for PDAC and has been a focal point in diagnostic strategies, but its sensitivity and specificity are not sufficient for early and accurate detection. To address this issue, we introduce a synergistic approach combining CA 19-9 levels with a graphene oxide (GO)-based blood test.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!